| Deborah Jean Brown, NP | |
|
130 Fisher Rd Unit 1, Berlin, VT 05602-8132 | |
| (802) 371-4100 | |
| Not Available |
| Full Name | Deborah Jean Brown |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 130 Fisher Rd Unit 1, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336424845 | NPI | - | NPPES |
| 1019875 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 101.0080472 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Vermont Medical Center | Barre, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Vermont Medical Center Inc | 9335138817 | 204 |
News Archive
Entellus Medical today announced that it has entered into a licensing agreement with Acclarent, Inc. in order to resolve their patent lawsuit. The license agreement is royalty bearing to Acclarent.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Progen Pharmaceuticals Limited has announced the final stage 1 results of its Phase 2 trial of PI-88 in patients who had previously undergone surgical removal of liver cancer.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Team from the Medical University of Vienna, led by Harald Noedl from the Institute of Specific Prophylaxis and Tropical Medicine, is developing a new treatment concept for complex malaria in Bangladesh. This treatment is intended to significantly cut the mortality rate and could save the lives of tens of thousands of children.
› Verified 1 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
Entellus Medical today announced that it has entered into a licensing agreement with Acclarent, Inc. in order to resolve their patent lawsuit. The license agreement is royalty bearing to Acclarent.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Progen Pharmaceuticals Limited has announced the final stage 1 results of its Phase 2 trial of PI-88 in patients who had previously undergone surgical removal of liver cancer.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Team from the Medical University of Vienna, led by Harald Noedl from the Institute of Specific Prophylaxis and Tropical Medicine, is developing a new treatment concept for complex malaria in Bangladesh. This treatment is intended to significantly cut the mortality rate and could save the lives of tens of thousands of children.
› Verified 1 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Entellus Medical today announced that it has entered into a licensing agreement with Acclarent, Inc. in order to resolve their patent lawsuit. The license agreement is royalty bearing to Acclarent.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Progen Pharmaceuticals Limited has announced the final stage 1 results of its Phase 2 trial of PI-88 in patients who had previously undergone surgical removal of liver cancer.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Team from the Medical University of Vienna, led by Harald Noedl from the Institute of Specific Prophylaxis and Tropical Medicine, is developing a new treatment concept for complex malaria in Bangladesh. This treatment is intended to significantly cut the mortality rate and could save the lives of tens of thousands of children.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Jean Brown, NP 130 Fisher Rd Unit 1, Berlin, VT 05602-8132 Ph: (802) 371-4100 | Deborah Jean Brown, NP 130 Fisher Rd Unit 1, Berlin, VT 05602-8132 Ph: (802) 371-4100 |
News Archive
Entellus Medical today announced that it has entered into a licensing agreement with Acclarent, Inc. in order to resolve their patent lawsuit. The license agreement is royalty bearing to Acclarent.
Today, the U.S. Food and Drug Administration announced a final rule for the unique device identification system that, once implemented, will provide a consistent way to identify medical devices.
Progen Pharmaceuticals Limited has announced the final stage 1 results of its Phase 2 trial of PI-88 in patients who had previously undergone surgical removal of liver cancer.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Team from the Medical University of Vienna, led by Harald Noedl from the Institute of Specific Prophylaxis and Tropical Medicine, is developing a new treatment concept for complex malaria in Bangladesh. This treatment is intended to significantly cut the mortality rate and could save the lives of tens of thousands of children.
› Verified 1 days ago
Ms. Quincy Campbell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Rd, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
Christina Marie Tourangeau, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Road, Suite 200, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
David Alexander Segel, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-225-7000 | |
Karen Gibbs, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 142 Woodridge Rd, Berlin, VT 05602 Phone: 802-371-4700 | |
Abbey Lynne Rouleau, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Cvmc Palliative Care, 130 Fisher Road 2nd Floor, Berlin, VT 05602 Phone: 802-371-5372 | |
Margaret Jones, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-471-2100 | |
Morgan Lamson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Central Vermont Medical Center, 130 Fisher Road, Berlin, VT 05602 Phone: 802-371-4700 Fax: 802-371-4720 |